Biologics Market Global Trends, Market Share, Industry Size, Growth, Opportunities and Market Forecast – 2021 to 2027

The Biologics Market was valued at approximately USD 302.63 billion in 2020, and it is expected to reach USD 509.23 billion by 2027, registering a CAGR of 9% during the forecast period, 2021-2027.

Biologics are drugs that exist in the form of genetically engineered proteins derived from human genes. According to the US FDA, biologics may consist of sugars, proteins or nucleic acids, or complex combinations of these substances, or they may consist of living entities such as cells and tissues. Most biologics are complex mixtures that cannot be readily characterized or identified, are heat sensitive, and susceptible to microbial contamination. A biological product derived from a variety of natural sources, such as animals, humans, or microorganisms. These products consist of vaccines, blood and blood components, allergies, somatic cells, gene therapy, tissue, and recombinant therapeutic proteins. Processes such as advanced biotechnology and complex processes are used to manufacture biological products. Biologics’ diverse products are monoclonal antibodies, vaccines, recombinant hormones/proteins, gene-based biologics, cell-based biologics, and others. They are used in applications such as autoimmune diseases, cancer, infectious diseases, rare diseases, and others.

Market Segments

By Product Type

• Monoclonal Antibodies
• Vaccines
• Recombinant Hormones/Proteins
• Cellular Based Biologics
• Gene Based Biologics

By Application

• Cancer
• Infectious Diseases
• Autoimmune Diseases
• Others

By End-use

• Hospitals
• Clinics
• Diagnostic Centers
• Others

Key Players

Key players operating in the global biologics market include Bristol-Myers Squibb Company (BMS), Merck & Co., Inc., Roche AG, Merck KGaA, AstraZeneca Plc, Regeneron Pharmaceuticals, Inc, Novartis International AG, Pfizer, Inc., Amgen, Inc., AbbVie, Inc., Sanofi S.A., Eli Lilly & Company, Novo Nordisk A/S, Johnson & Johnson, GlaxoSmithKline Plc, Teva Pharmaceutical Industries Ltd., Ipsen S.A., and Allergan Plc.

Scope of the Report

The research study analyzes the global Biologics industry from 360-degree analysis of the market thoroughly delivering insights into the market for better business decisions, considering multiple aspects some of which are listed below as:

Recent Developments

o Market Overview and growth analysis
o Import and Export Overview
o Volume Analysis
o Current Market Trends and Future Outlook
o Market Opportunistic and Attractive Investment Segment

Geographic Coverage

o North America Market Size and/or Volume
o Latin America Market Size and/or Volume
o Europe Market Size and/or Volume
o Asia-Pacific Market Size and/or Volume
o Rest of the world Market Size and/or Volume

Key Questions Answered by Biologics Market Report

1. What was the Biologics Market size in 2019 and 2020; what are the estimated growth trends and market forecast (2021-2027).

2. What will be the CAGR of the Biologics Market during the forecast period (2021-2027)?
3. Which segments (product type/applications/end-user) were most attractive for investments in 2021? How these segments are expected to grow during the forecast period (2021-2027).
4. Which manufacturer/vendor/players in the Biologics Market was the market leader in 2020?
5. Overview on the existing product portfolio, products in the pipeline, and strategic initiatives taken by key vendors in the market.